What is it about?
Hepatocellular carcinoma is the most frequent type of primary liver cancer and one of the prominent causes of cancer mortality. Extracellular vesicles are membranous vesicles originating from several cells, which can be exploited as delivery vehicles for microRNAs, protecting them from degradation. This proof-of-concept study supports the development of innovative therapeutic strategies for liver cancer via extracellular vesicles-mediated microRNA delivery.
Featured Image
Photo by National Cancer Institute on Unsplash
Read the Original
This page is a summary of: Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation, Cells, December 2019, MDPI AG,
DOI: 10.3390/cells8121560.
You can read the full text:
Resources
Mesenchymal Cell News
Mesenchymal Cell News
Cells
Open Access Version
Open Access Version at PubMed Central
PubMed Central link
Cancer Gene Therapy Week
Gene Therapy; Researchers from Department of Research Describe Findings in Gene Therapy
Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy
Translational Cancer Research doi: 10.21037/tcr.2017.09.29
Contributors
The following have contributed to this page
